Total Payments
$1.9M
2024 Payments
$273,213
Companies
44
Transactions
1,717
Medicare Patients
10,154
Medicare Billing
$7.2M
Payment Breakdown by Category
Other$1.4M (76.3%)
Consulting$203,150 (10.9%)
Travel$142,191 (7.6%)
Food & Beverage$50,139 (2.7%)
Research$44,611 (2.4%)
Gifts$40.59 (0.0%)
Education$6.96 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.3M | 271 | 70.2% |
| Consulting Fee | $203,150 | 77 | 10.9% |
| Travel and Lodging | $142,191 | 432 | 7.6% |
| Honoraria | $85,549 | 28 | 4.6% |
| Food and Beverage | $50,139 | 890 | 2.7% |
| Unspecified | $44,611 | 6 | 2.4% |
| Grant | $20,796 | 2 | 1.1% |
| Compensation for serving as faculty or as a speaker for a medical education program | $8,663 | 9 | 0.5% |
| Gift | $40.59 | 1 | 0.0% |
| Education | $6.96 | 1 | 0.0% |
Payments by Type
General
$1.8M
1,711 transactions
Research
$44,611
6 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $511,332 | 400 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $390,184 | 200 | $0 (2024) |
| EyePoint Pharmaceuticals US, Inc. | $202,473 | 143 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $128,055 | 134 | $0 (2019) |
| Alimera Sciences, Inc. | $94,665 | 132 | $0 (2024) |
| Allergan, Inc. | $88,258 | 141 | $0 (2022) |
| Coherus Biosciences Inc. | $82,085 | 60 | $0 (2024) |
| Spark Therapeutics, Inc. | $81,374 | 46 | $0 (2021) |
| Genentech USA, Inc. | $74,682 | 102 | $0 (2024) |
| ABBVIE INC. | $60,488 | 55 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $273,213 | 221 | Regeneron Healthcare Solutions, Inc. ($101,311) |
| 2023 | $289,152 | 271 | Regeneron Healthcare Solutions, Inc. ($90,328) |
| 2022 | $362,706 | 275 | Mallinckrodt Hospital Products Inc. ($113,256) |
| 2021 | $216,985 | 162 | Mallinckrodt Hospital Products Inc. ($80,081) |
| 2020 | $187,195 | 112 | Mallinckrodt Hospital Products Inc. ($98,626) |
| 2019 | $332,427 | 344 | Mallinckrodt Enterprises LLC ($116,754) |
| 2018 | $90,337 | 147 | NotalVision ($25,009) |
| 2017 | $108,182 | 185 | Genentech USA, Inc. ($37,788) |
All Payment Transactions
1,717 individual payment records from CMS Open Payments — Page 1 of 69
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $3,760.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/20/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $3,760.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/20/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $1,880.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/18/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Grant | Cash or cash equivalent | $7,798.50 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: EYE CARE | ||||||
| 12/12/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $28.59 | General |
| Category: EYE CARE | ||||||
| 12/05/2024 | Sandoz Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $31.65 | General |
| Category: Ophthalmology | ||||||
| 11/21/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/20/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Grant | Cash or cash equivalent | $12,997.50 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $71.13 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/20/2024 | Harrow Eye, LLC | IHEEZO (Drug), TRIESENCE | Food and Beverage | In-kind items and services | $34.45 | General |
| Category: OPTOMETRY | ||||||
| 11/19/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Travel and Lodging | In-kind items and services | $122.57 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/19/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Travel and Lodging | In-kind items and services | $27.80 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/18/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Travel and Lodging | In-kind items and services | $341.98 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/15/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Travel and Lodging | In-kind items and services | $149.30 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/14/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $39.64 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | OZURDEX (Drug) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: EYE CARE | ||||||
| 11/13/2024 | ABBVIE INC. | OZURDEX (Drug) | Travel and Lodging | In-kind items and services | $104.21 | General |
| Category: EYE CARE | ||||||
| 11/12/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $28.67 | General |
| Category: Ophthalmology | ||||||
| 11/01/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Travel and Lodging | In-kind items and services | $50.85 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/29/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $10,580.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/29/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,290.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/29/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,290.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/29/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,120.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Travel and Lodging | In-kind items and services | $264.70 | General |
| Category: OPHTHALMOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Comparison of intravitreal triamcinolone acetonide, dexamethasone implant and fluocinolone implant on recurrence rates in chronic noninfectious posterior uveitis and the effect of hyperreflective inner retinal line (HIRL) | EyePoint Pharmaceuticals US, Inc. | $28,060 | 1 |
| CHART REVIEW | Alimera Sciences, Inc. | $11,600 | 2 |
| PALADIN | Alimera Sciences, Inc. | $4,951 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 2,892 | 25,115 | $7.5M | $2.7M |
| 2022 | 22 | 2,707 | 10,049 | $4.6M | $2.0M |
| 2021 | 21 | 1,866 | 5,186 | $2.5M | $1.2M |
| 2020 | 18 | 2,689 | 5,463 | $3.1M | $1.3M |
Total Patients
10,154
Total Services
45,813
Medicare Billing
$7.2M
Procedure Codes
88
All Medicare Procedures & Services
88 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 152 | 2,078 | $3.8M | $1.4M | 37.5% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 30 | 14,400 | $642,721 | $417,977 | 65.0% |
| 67028 | Injection of drug into eye | Office | 2023 | 228 | 1,275 | $899,800 | $125,014 | 13.9% |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | Office | 2023 | 23 | 1,020 | $366,825 | $120,962 | 33.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 599 | 1,305 | $339,300 | $120,738 | 35.6% |
| J3590 | Unclassified biologics | Office | 2023 | 49 | 96 | $407,010 | $116,774 | 28.7% |
| J3490 | Unclassified drugs | Office | 2023 | 16 | 71 | $240,900 | $74,350 | 30.9% |
| 92134 | Imaging of retina | Office | 2023 | 606 | 1,994 | $159,520 | $57,689 | 36.2% |
| 67041 | Removal of membrane of retina | Facility | 2023 | 37 | 45 | $101,700 | $40,368 | 39.7% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2023 | 21 | 203 | $77,315 | $32,280 | 41.8% |
| 67113 | Complex repair of detached retina and drainage of eye fluid between lens and retina | Facility | 2023 | 19 | 35 | $115,150 | $31,650 | 27.5% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 12 | 170 | $88,397 | $28,906 | 32.7% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 168 | 182 | $44,590 | $18,059 | 40.5% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 133 | 166 | $41,500 | $15,633 | 37.7% |
| 92273 | Measurement of retinal and optic nerve function | Office | 2023 | 94 | 94 | $23,500 | $9,157 | 39.0% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Facility | 2023 | 12 | 13 | $28,795 | $8,283 | 28.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 54 | 54 | $18,360 | $5,921 | 32.3% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 108 | 150 | $14,250 | $5,168 | 36.3% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 278 | 286 | $18,590 | $5,099 | 27.4% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 21 | 24 | $14,400 | $4,114 | 28.6% |
| 92250 | Photography of the retina | Office | 2023 | 96 | 114 | $8,550 | $3,226 | 37.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 40 | $7,400 | $2,750 | 37.2% |
| 66820 | Removal of recurring cataract in lens capsule by stab incision | Facility | 2023 | 11 | 12 | $14,040 | $2,211 | 15.7% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 13 | 21 | $2,730 | $1,346 | 49.3% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 27 | 31 | $3,875 | $1,313 | 33.9% |
About Dr. Daniel Kiernan, MD
Dr. Daniel Kiernan, MD is a Ophthalmology healthcare provider based in Sarasota, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/25/2008. The National Provider Identifier (NPI) number assigned to this provider is 1376790022.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Kiernan, MD has received a total of $1.9M in payments from pharmaceutical and medical device companies, with $273,213 received in 2024. These payments were reported across 1,717 transactions from 44 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.3M).
As a Medicare-enrolled provider, Kiernan has provided services to 10,154 Medicare beneficiaries, totaling 45,813 services with total Medicare billing of $7.2M. Data is available for 4 years (2020–2023), covering 88 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Sarasota, FL
- Active Since 08/25/2008
- Last Updated 09/09/2024
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1376790022
Products in Payments
- ACTHAR (Biological) $518,238
- EYLEA (Biological) $354,832
- YUTIQ (Drug) $198,723
- EYLEA HD (Biological) $136,785
- OZURDEX (Drug) $128,978
- Cimerli (Biological) $82,132
- Lucentis (Biological) $74,057
- LUXTURNA (Biological) $69,621
- ILUVIEN (Drug) $59,371
- EYLEA AFLIBERCEPT INJECTION (Biological) $31,228
- Syfovre (Drug) $28,880
- ForeseeHome (Device) $27,213
- IHEEZO (Drug) $23,245
- BEOVU (Drug) $18,687
- Iluvien (Drug) $16,863
- ILUVIEN (Biological) $16,164
- XIPERE (Drug) $11,244
- DEXYCU (Drug) $4,100
- Spectralis (Device) $1,700
- Non-Covered Product (Drug) $1,463
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Sarasota
Dr. Jody Abrams, M.d, M.D
Ophthalmology — Payments: $364,132
Ophthalmology $364,132
Keye Wong, M.d, M.D
Ophthalmology — Payments: $29,735
Ophthalmology $29,735
Dr. Marc Levy, Md, MD
Ophthalmology — Payments: $18,348
Ophthalmology $18,348
Tanuj Banker, M.d, M.D
Ophthalmology — Payments: $16,580
Ophthalmology $16,580
John Niffenegger, Md, MD
Ophthalmology — Payments: $15,775
Ophthalmology $15,775
Melvin Chen, Md, MD
Ophthalmology — Payments: $4,621
Ophthalmology $4,621